Non-Invasive Ultrasound Nerve Repair System MicroPulse Completes First Clinical Case: Spinal Cord Injury Patient Regains Partial Sensation
Israeli company NeuroAid's MicroPulse focused ultrasound system helped a T6 spinal cord injury patient recover partial lower limb sensory function in its first human clinical trial.
On August 9, 2028, Israeli medical technology company NeuroAid announced positive results from the first human clinical trial of its MicroPulse focused ultrasound nerve repair system.
A patient with complete T6 spinal cord injury from a car accident three years ago recovered partial tactile and temperature sensation in both thighs after eight weeks of MicroPulse treatment. While voluntary movement has not yet returned, sensory recovery indicates that spinal nerve pathways are rebuilding.
MicroPulse uses focused ultrasound beams outside the skull to precisely stimulate neural stem cell proliferation and axon regeneration at the spinal cord injury site. Unlike electrical stimulation, ultrasound can penetrate bone without surgical implantation.
NeuroAid said a larger Phase II clinical trial will launch in 2029, planning to enroll 100 spinal cord injury patients.
Disclaimer
Content is AI-generated. Do not use it as a basis for real decisions. Do not cite it as factual reporting.